STOCK TITAN

Israel Acquisitions (OTC: ISLUF) extends BCA termination to Apr 15, 2026

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
425

Rhea-AI Filing Summary

Israel Acquisitions Corp entered a third amendment to its Business Combination Agreement with Gadfin Ltd. and Gadfin Regev Holdings Ltd. dated March 13, 2026. The amendment revises Section 7.1(d) to extend the agreements termination date to April 15, 2026, with all other termination rights under the BCA unchanged. The full text of the Third BCA Amendment is filed as Exhibit 2.4 and the summary is qualified in its entirety by that exhibit.

Positive

  • None.

Negative

  • None.

Insights

Third amendment extends deal timeline to April 15, 2026 while preserving other termination rights.

The amendment formally extends the termination date in Section 7.1(d) of the Business Combination Agreement to April 15, 2026. This change delays the deadline for closing without altering other contractual termination triggers.

Key dependencies remain: performance and closing conditions in the BCA and any required approvals. Subsequent filings or the exhibit text will show whether additional concessions or milestones accompany the extension.

 

 

 

United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 8-K

 

Current Report

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 13, 2026

 

ISRAEL ACQUISITIONS CORP

(Exact Name of Registrant as Specified in its Charter)

 

Cayman Islands   001-41593   87-3587394
(State or other jurisdiction of
incorporation)
  (Commission
File Number)
  (I.R.S. Employer
Identification No.)

 

12600 Hill Country Blvd, Building R, Suite 275

Bee Cave, Texas

  78738
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (800) 508-1531

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

x Written communications pursuant to Rule 425 under the Securities Act

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol(s)*
  Name of each exchange on
which registered
Units, each consisting of one Class A ordinary share and one redeemable warrant   ISLUF   N/A
Class A ordinary shares, par value $0.0001 per share   ISRLF   N/A
Redeemable warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share   ISLWF   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

*The registrant’s units, Class A ordinary shares, par value $0.0001 per share and warrants each trade on the OTC Markets under the trading symbols “ISLUF”, “ISRLF” and “ISLWF”, respectively.

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

As previously reported in the Current Reports on Form 8-K, filed with the U.S. Securities and Exchange Commission (“SEC”) on January 27, 2025 and July 3, 2025, and the Current Report on Form 8-K/A filed March 9, 2026, Israel Acquisitions Corp, a Cayman Islands exempted company (the “Company”) entered into a business combination agreement on January 26, 2025, as amended on July 2, 2025 and December 31, 2025 (the “BCA”) with Gadfin Ltd., a company domiciled in Israel (“Gadfin”).

 

Pursuant to Section 8.3 of the BCA, the BCA may be amended, modified or supplemented by an agreement in writing executed by the Company and Gadfin. On March 13, 2026, the Company, Gadfin, and Gadfin Regev Holdings Ltd., a company domiciled in Israel entered into a third amendment to the BCA (the “Third BCA Amendment”). Pursuant to the Third BCA Amendment, the Company and Gadfin agreed to revise Section 7.1(d) to extend the termination date to April 15, 2026. All other termination rights under the BCA remain.

 

The foregoing description of the Third BCA Amendment is only a summary and is qualified in its entirety by reference to the full text of the Third BCA Amendment, which is attached hereto as Exhibit 2.4, and incorporated by reference herein.

 

Item 9.01. Financial Statements and Exhibits.

 

Exhibit
No.
  Description
2.1*   Business Combination Agreement, dated as of January 26, 2025, by and among, Israel Acquisitions Corp and Gadfin Ltd. (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed by the Company on January 27, 2025)
     
2.2   Amendment No. 1 to the Business Combination Agreement, dated July 2, 2025, by and among Israel Acquisitions Corp, Gadfin Ltd., and Gadfin Regev Holdings Ltd. (incorporated by reference to Exhibit 2.2 to the Current Report on Form 8-K filed by the Company on July 3, 2025)
     
2.3   Amendment No. 2 to the Business Combination Agreement, dated December 31, 2025, by and among Israel Acquisitions Corp, Gadfin Ltd., and Gadfin Regev Holdings Ltd. (incorporated by reference to Exhibit 2.3 to the Current Report on Form 8-K/A filed by the Company on March 9, 2026).
     
2.4   Amendment No. 3 to the Business Combination Agreement, dated March 13, 2026, by and among Israel Acquisitions Corp, Gadfin Ltd., and Gadfin Regev Holdings Ltd.
     
104   Cover Page Interactive Data File (embedded within the Inline document)

 

* Certain exhibits and schedules to this Exhibit have been omitted in accordance with Regulation S-K, Item 601(a)(5). The Company agrees to furnish supplementally a copy of all omitted exhibits and schedules to the SEC upon its request.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ISRAEL AcquisitionS Corp
   
  By: /s/ Ziv Elul
    Name: Ziv Elul
    Title: Chief Executive Officer and Director
   
Dated: March 17, 2026  

 

 

 

FAQ

What did Israel Acquisitions Corp (ISLUF) change in the Business Combination Agreement?

They extended the agreements termination date to April 15, 2026. The amendment revises Section 7.1(d) and is filed as Exhibit 2.4, while all other termination rights under the BCA remain in effect.

When was the Third BCA Amendment between ISLUF and Gadfin executed?

The Third BCA Amendment was executed on March 13, 2026. The press text states the amendment date and notes the full amendment is attached as Exhibit 2.4 to the report.

Does the amendment change other termination rights in the agreement?

No, all other termination rights remain. The filing explicitly states the extension applies to Section 7.1(d) only and that other termination provisions are unchanged.

Where can I review the full terms of the Third BCA Amendment?

The full amendment is attached as Exhibit 2.4 to the Form 8-K. The Form 8-K summary says the description is qualified in its entirety by the Exhibit, which contains the complete text.

Does the filing state any new closing conditions or consideration changes?

No new closing conditions or changes in consideration are disclosed in the summary. The filing limits the disclosed change to extending the termination date and refers readers to Exhibit 2.4 for full terms.